Close Menu

NEW YORK, Oct. 12 – Shares in Cepheid skyrocketed nearly 50 percent during mid-day trading on Friday after reports surfaced that an employee of NBC in New York was diagnosed with anthrax.

As of 2:00 p.m. EST, shares in the company, which makes and sells technology that performs genetic testing, were trading up more than 48 percent at $8.10 on the Nasdaq but eased a bit one hour later.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers trace DNA on a clay pipe found at a former slave site to a population that lives in what is now Sierra Leone, the Washington Post reports.

Two researchers report on their genetic analysis of samples from a shawl thought to belong to a victim of Jack the Ripper, ScienceInsider reports.

Japan is to release rules governing some gene-edited food, according to NHK World.

In PLOS this week: computational strategy for improving gene set analysis testing, miRNAs linked to sleep apnea, and more.